EDC for nutraceutical clinical trials: dietary supplement and functional food studies with 21 CFR Part 11–aligned controls.
21 CFR Part 11 aligned · HIPAA-aligned security · No credit card required
Nutraceutical trials depend on a clear record of what each participant actually used, when they used it, and whether the observed outcome can reasonably be connected to the product exposure. That can be more complicated than it looks. A study may involve capsules, powders, beverages, fortified foods, probiotics, botanical extracts, or multi-ingredient formulations. Each product can have batch numbers, dosing instructions, storage requirements, and compliance expectations that need to be documented consistently. Capture lets study teams configure CRFs around the product and protocol rather than using a generic medication log. Forms can track assigned product, lot or batch, dose, frequency, start and stop dates, missed doses, product returns, and reasons for non-adherence. When the study includes multiple arms or product versions, those fields can be structured so monitors and analysts can compare exposure across groups without rebuilding spreadsheets after the fact. This matters for both efficacy interpretation and safety review. If a participant reports an adverse event, the team needs to know what product they were taking and whether they were compliant at the time. If an endpoint improves, the analysis team needs confidence that the participant actually followed the intervention. A well-designed EDC makes those links visible in the study record instead of leaving them buried in site notes or offline trackers.
Many nutraceutical studies rely on participant-reported information that does not fit neatly into a site visit form. Participants may need to record daily intake, symptoms, gastrointestinal tolerance, sleep, energy, mood, diet changes, exercise, or other lifestyle factors that could affect the endpoint. If those reports are collected on paper or in a separate survey tool, teams often spend unnecessary time reconciling dates, participant IDs, and missing entries. With Capture, ePRO can sit beside the EDC instead of operating as a disconnected system. Participants can complete scheduled diaries and questionnaires while site teams review the resulting data from the same platform used for CRFs, consent, and safety. Skip logic and structured question types help keep diaries focused, while the study team can configure reminders and assessment windows around the protocol. For nutraceutical teams, this reduces the operational burden of patient-reported data. Daily adherence, tolerability, and symptom context can be reviewed alongside clinical measures and safety forms. That is especially useful when the endpoint is sensitive to behavior outside the clinic, such as diet, sleep, activity, or rescue medication use. The goal is not to collect more data for its own sake; it is to collect the context needed to interpret the results with confidence.
Nutraceutical studies are often designed for multiple audiences: internal product decisions, clinical substantiation, regulatory review, health-care professional education, and publication. Each audience expects the dataset to be traceable. The team should be able to show how participants were consented, what data was collected at each visit, how adherence was measured, which records changed during review, and what final dataset was exported for analysis. Capture supports that workflow with audit trails, role-based access, electronic signatures, and structured exports. Data managers can review forms, issue queries, and resolve inconsistencies before lock. Investigators and monitors can work from the same participant record, reducing the chance that final analysis depends on undocumented spreadsheet fixes. For regulated or higher-risk studies, Enterprise documentation can support the sponsor's validation and qualification process. This is important because nutraceutical studies often run with lean teams and tight budgets. A lightweight study build still needs disciplined data governance. By keeping EDC, eConsent, ePRO, safety, and export workflows in one platform, Capture gives nutraceutical teams a practical path to a publication-ready dataset without adopting an enterprise system built for large pharmaceutical trials.
Overview
Nutraceutical clinical trials evaluate dietary supplements, functional foods, and related products in human subjects. Your EDC must support consent, CRFs, safety and compliance capture, and full auditability for regulatory and publication use. Capture provides EDC, eConsent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls and HIPAA-aligned infrastructure, so nutraceutical study teams can run compliant trials without enterprise cost.
Nutraceutical studies often have smaller budgets and lean teams. You need one system that handles consent, data capture, compliance (e.g., supplement intake), and optional ePRO without lengthy implementation or per-seat pricing. Enterprise EDC often targets pharma with pricing that doesn’t fit. Capture is built for flexible study designs with controls aligned with 21 CFR Part 11 and pricing that scales with study size.
FAQ
Explore the platform with a free sandbox. No sales call required.
Explore platform